Related Experiment Videos
Cytarabine: cytocidal effect on normal and leukemic lymphocytes. Synergism with x rays and comparison with
Experimental and Molecular Pathology
|February 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sensitivity of latent cancer to chemotherapy.
Medical hypotheses·1992
Intractable chronic lymphocytic leukemia and interferon.
Medical hypotheses·1991
An animal model for intractable chronic lymphocytic leukemia.
Medical hypotheses·1990
Differences between responsive and intractable chronic lymphocytic leukemia.
Medical hypotheses·1990
Pathogenesis of intractable chronic lymphocytic leukemia (ICLL).
Medical hypotheses·1989
Multifaceted renoprotection by SMTP-44D in diabetic nephropathy: Targeting inflammation, oxidative stress, and insulin resistance.
Experimental and molecular pathology·2026
Csf1-Csf1r expression and late circulating CSF1 elevation during P23H retinal degeneration.
Experimental and molecular pathology·2026
Neutrophil extracellular traps induced by a monoclonal anti-phosphatidylserine/prothrombin antibody activate platelets in vitro.
Experimental and molecular pathology·2026
Hidden proteins encoded by non-canonical open reading frames: A review.
Experimental and molecular pathology·2026
Automated imaging workflow for FISH-stained tissue microarrays enables assessment of FGFR2 translocations in a large intrahepatic cholangiocarcinoma patient cohort.
Experimental and molecular pathology·2026
Charged to death: Energy drinks, smart drugs, and sudden cardiac death.
Experimental and molecular pathology·2026
Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.
Anesthesiology research and practice·2026
Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.
International journal of nanomedicine·2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Journal of hepatocellular carcinoma·2026